About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Efficacy/Safety of Lansoprazole in Patients With Frequent Heartburn

NCT00389948·28 sites·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

Novartis

Age

18–any

Sex

ALL

Healthy volunteers

Not accepted

You may be eligible if

1. Experiencing heartburn at least 2 days per week over the past month.
2. Having heartburn that responds to heartburn medication.
3. Be willing to discontinue the use of heartburn treatment for 7 days prior to inclusion in the study.

You may not be if

1. Having history of erosive esophagitis or gastroesophageal reflux disease diagnosed by a physician and confirmed by testing (endoscopy).
2. Be unwilling to take only the study medication, and antacid provided as a rescue medication for relief of acute heartburn during the study.

The record

StatusCompleted

PhasePhase 3

Taking part576

StartedJun 2006

UpdatedApr 16, 2007

Conditions

Where28

Clinical Research Consultants Inc.
Hoover, Alabama, United States
Huntsville, Alabama, United States
Radiant Research
Sierra Vista, Arizona, United States

Clareo Health | Efficacy/Safety of Lansoprazole in Patients With Frequent Heartburn